Skip to main content

Diabetes

  • Nielsen: Consumers with diabetes spend 35% more on OTC products

    Consumers with diabetes spend 35% more on OTC products than the average consumer, noted Jeff Gregori, group VP consumer and shopper analytics for Nielsen, during a recent presentation at the National Association of Chain Drug Stores Total Store Expo. “That’s hands down more than any other ailment,” he said, and it’s because they face so many challenges beyond their initial diagnosis.

  • J&J showcases new diabetes approach

    The front-end opportunity surrounding patients with diabetes is significant. Diabetes patients are spending between $1,000 and $2,500 each year on diabetes supplies alone, noted Sally Manoufar, senior manager health and wellness at Johnson & Johnson, during a recent GMDC webcast. According to Johnson & Johnson research, the front-end basket of a diabetes patient is five times larger than that of a patient who doesn’t have diabetes.

  • Diabetes prevention is untapped opportunity

    According to Medline chief marketing officer Stu Schneider, it’s time for retailers and consumer health companies to start looking at the current diabetes care market like an iceberg. With more than 37% of Americans diagnosed as prediabetic, the current market for diabetes management and monitoring is really just the tip of the iceberg.

  • Iceshot aims to revolutionize the diabetic community

    ADDISON, Texas -- There's a new reusable applicator that freezes injection sites to reduce pain and discomfort, and it's targeted specifically at people with diabetes. 

    Iceshot is a personal, topical, dermal numbing unit that is used to numb the skin prior to taking insulin injections.  Within a few quick seconds of holding Iceshot to the skin, the pain of the injections is eased dramatically.

    USES:  

    Temporarily relieves pain associated with insulin injections.

    DIRECTIONS:

  • Express Scripts implements latest Diabetes Care Value Program

    ST. LOUIS - Express Scripts on Wednesday announced the launch of its Diabetes Care Value Program, the industry's most comprehensive approach to improve pharmacy care while controlling plan costs for people with diabetes.

  • Johnson & Johnson leading the way in diabetes collaboration

    NEW BRUNSWICK, N.J. – The statistics are sobering. Nearly 30 million Americans have diabetes, with an estimated 86 million more with pre-diabetes, resulting in $322 Billion annually in medical costs.
     
    Johnson & Johnson has been a leader in diabetes management and treatment for years, providing medication and devices to support the needs of the diabetes patient and their caregivers. 

  • Jumpstart Foundry and GMDC partner on Health:Further - Retail Tomorrow event

    NASHVILLE, Tenn., – Jumpstart Foundry and Global Market Development Center on Tuesday partnered to advance consumer health and wellness innovations through its Health:Further and Retail Tomorrow initiatives.

    The partnership is expected to help fuel the growing movement from physician-centric to patient-centric care, where increasingly consumers are driving health care insurance choices, product purchases and wellness – a “health care = self care” model.

  • IMS Health: Adherence, persistence issues keep diabetes costs high

    PARSIPPANY, N.J. — The IMS Institute for Healthcare Informatics on Tuesday released a series of reports on type 2 diabetes and the effects of low persistence and adherence on health system. “Improving Type 2 Diabetes Therapy Adherence and Persistence” looked at five health systems, including the United States, Mexico, the United Kingdom, Germany, Brazil and Saudi Arabia. 
     
X
This ad will auto-close in 10 seconds